Our company has business talks with pharmaceutical and trading companies from all over the world at 2019CPHI exhibition.

Date：2019/10/11

June 18, 2019-June 20, 2019, Enki Biotechnology (shanghai) Limited. Took part in the 2019 CPhI Shanghai. This exhibition is of great significance for Enki to expand the international middle and high-end market in the future. The exhibitors are general manager, marketing personnel and scientific research personnel and so on. They will Enki biology's main products (such as: Tolvaptan series, Glatiramer series, Evogliptin series and other products) to promote and display to customers, the exhibition on the day of the signing of a number of cooperation intention agreements. Enki biology has been adhering to all in accordance with the national industry standards, has always been walking in the front of pharmaceutical intermediate research and development and production, to contribute to the cause of human health; Customers with Enki Biotechnology cooperation more assured, more in-depth, for Enki biological continuous development and innovation laid a solid foundation.